{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SGHT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:07:20.839Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10680,"canonical_name":"Sight Sciences, Inc.","cik":"0001531177","uei":null,"lei":null,"duns":null,"ticker":"SGHT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":62,"clinical":1},"count":63,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-10-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-414272","accession_number":"0001193125-26-414272","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-10-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-414275","accession_number":"0001193125-26-414275","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-10-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-414277","accession_number":"0001193125-26-414277","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-10-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-414281","accession_number":"0001193125-26-414281","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-10-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-414283","accession_number":"0001193125-26-414283","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-02","url_slug":"/sec/cik-0001531177/144/0001959173-26-007224","accession_number":"0001959173-26-007224","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-02","url_slug":"/sec/cik-0001531177/144/0001959173-26-007229","accession_number":"0001959173-26-007229","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-02","url_slug":"/sec/cik-0001531177/144/0001959173-26-007241","accession_number":"0001959173-26-007241","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-007194","accession_number":"0001959173-26-007194","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-007196","accession_number":"0001959173-26-007196","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-10-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-007198","accession_number":"0001959173-26-007198","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-09-30","url_slug":"/sec/cik-0001531177/144/0001959173-26-007157","accession_number":"0001959173-26-007157","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-09-04","url_slug":"/sec/cik-0001531177/144/0001959173-26-006765","accession_number":"0001959173-26-006765","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-09-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-006603","accession_number":"0001959173-26-006603","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"3","title":"3 — Sight Sciences, Inc. — 2026-08-18","url_slug":"/sec/cik-0001531177/3/0001193125-26-355781","accession_number":"0001193125-26-355781","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-08-18","url_slug":"/sec/cik-0001531177/4/0001193125-26-355783","accession_number":"0001193125-26-355783","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-08-17","url_slug":"/sec/cik-0001531177/144/0001959173-26-006121","accession_number":"0001959173-26-006121","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-08-14","url_slug":"/sec/cik-0001531177/144/0001959173-26-006045","accession_number":"0001959173-26-006045","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-08-13","url_slug":"/sec/cik-0001531177/144/0001959173-26-005984","accession_number":"0001959173-26-005984","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-08-12","url_slug":"/sec/cik-0001531177/144/0001959173-26-005935","accession_number":"0001959173-26-005935","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"HAYDEN JEREMY B.","title":"Officer","shares":20918,"usd_value":165879,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001959173-26-005895","importance":40.033175724},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-08-11","url_slug":"/sec/cik-0001531177/144/0001959173-26-005895","accession_number":"0001959173-26-005895","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Sight Sciences, Inc. — 2026-08-10","url_slug":"/sec/cik-0001531177/8-k/0001193125-26-341346","accession_number":"0001193125-26-341346","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Sight Sciences, Inc. — 2026-08-05","url_slug":"/sec/cik-0001531177/10-q/0001193125-26-335204","accession_number":"0001193125-26-335204","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Sight Sciences, Inc. — 2026-08-05","url_slug":"/sec/cik-0001531177/8-k/0001193125-26-335092","accession_number":"0001193125-26-335092","importance":35},{"ts":"2026-07-06","kind":"sec.form144","reporter":"HAYDEN JEREMY B.","title":"Officer","shares":12733,"usd_value":70132,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005124","importance":40.01402642},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Badawi David","title":"Officer, Director","shares":7418,"usd_value":40858,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005125","importance":40.00817152},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"HAYDEN JEREMY B.","title":"Chief Legal Officer","shares":12733,"price_per_share":5.508,"usd_value":70133,"security_title":"Common Stock","importance":35.070133364},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Badawi David","title":"Chief Technology Officer","shares":7418,"price_per_share":5.508,"usd_value":40858,"security_title":"Common Stock","importance":35.040858344},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/144/0001959173-26-005124","accession_number":"0001959173-26-005124","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/144/0001959173-26-005125","accession_number":"0001959173-26-005125","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296593","accession_number":"0001193125-26-296593","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296594","accession_number":"0001193125-26-296594","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296596","accession_number":"0001193125-26-296596","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296597","accession_number":"0001193125-26-296597","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296589","accession_number":"0001193125-26-296589","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001531177/4/0001193125-26-296590","accession_number":"0001193125-26-296590","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Bauerlein Alison","title":"Officer","shares":24184,"usd_value":129503,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001959173-26-005093","importance":40.025900582},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Rodberg James","title":"Officer","shares":6902,"usd_value":36960,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001959173-26-005098","importance":40.007391902},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Bauerlein Alison","title":"Chief Operating Officer","shares":24184,"price_per_share":5.36,"usd_value":129626,"security_title":"Common Stock","importance":35.12962624},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Rodberg James","title":"Chief Financial Officer","shares":6902,"price_per_share":5.36,"usd_value":36995,"security_title":"Common Stock","importance":35.03699472},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-02","url_slug":"/sec/cik-0001531177/144/0001959173-26-005093","accession_number":"0001959173-26-005093","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-02","url_slug":"/sec/cik-0001531177/144/0001959173-26-005098","accession_number":"0001959173-26-005098","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Badawi Paul","title":"President and CEO","shares":28684,"price_per_share":5.42,"usd_value":155467,"security_title":"Common Stock","importance":35.15546728},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Taylor Brenton","title":"EVP, Operations & R&D","shares":2829,"price_per_share":5.42,"usd_value":15333,"security_title":"Common Stock","importance":35.01533318},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-005034","accession_number":"0001959173-26-005034","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-07-01","url_slug":"/sec/cik-0001531177/144/0001959173-26-005035","accession_number":"0001959173-26-005035","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-06-11","url_slug":"/sec/cik-0001531177/4/0001193125-26-267752","accession_number":"0001193125-26-267752","importance":30},{"ts":"2026-06-10","kind":"sec.insider.p","reporter":"Encrantz Staffan","title":null,"shares":14100,"price_per_share":4.879,"usd_value":68794,"security_title":"Common Stock","importance":50.0687939},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Sight Sciences, Inc. — 2026-06-05","url_slug":"/sec/cik-0001531177/8-k/0001193125-26-259546","accession_number":"0001193125-26-259546","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-06-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-259557","accession_number":"0001193125-26-259557","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-06-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-259570","accession_number":"0001193125-26-259570","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-06-05","url_slug":"/sec/cik-0001531177/4/0001193125-26-259573","accession_number":"0001193125-26-259573","importance":30},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Burbach Gerhard F","title":null,"shares":28261,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Zurbay Donald","title":null,"shares":28261,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Mazzacco Catherine","title":null,"shares":28261,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Encrantz Staffan","title":null,"shares":28261,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Fountain Tamara","title":null,"shares":28261,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Sight Sciences, Inc. — 2026-05-19","url_slug":"/sec/cik-0001531177/4/0001193125-26-230957","accession_number":"0001193125-26-230957","importance":30},{"ts":"2026-05-18","kind":"sec.form144","reporter":"Bauerlein Alison","title":"Officer","shares":12728,"usd_value":65129,"security_title":"Common","approx_sale_date":"2026-05-18","accession_number":"0001959173-26-003721","importance":40.013025836},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Bauerlein Alison","title":"Chief Operating Officer","shares":12728,"price_per_share":5.12,"usd_value":65167,"security_title":"Common Stock","importance":35.06516736},{"ts":"2026-05-18","kind":"sec.filing","form_type":"144","title":"144 — Sight Sciences, Inc. — 2026-05-18","url_slug":"/sec/cik-0001531177/144/0001959173-26-003721","accession_number":"0001959173-26-003721","importance":30},{"ts":"2026-04-24","kind":"clinical.trial","reporter":"Sight Sciences, Inc.","title":"TearCare MGX™ System With and Without Warming Hold","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07365735","excerpt":"[\"Meibomian Gland Dysfunction (Disorder)\"]","importance":25}]}